Reimbursement, incentive - Open Access .click

Results 161 to 170 of about 14,098 (242)

The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies. [PDF]

Front Pharmacol
Simoens S +14 more
europepmc +1 more source

A New Dawn—Using Teletrials for Early Phase Drug Development: A Practical Guideline

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This article outlines a framework for tertiary trials centers on how to found satellite teletrial sites and prepare themselves for the pros and cons of this approach. ABSTRACT Introduction Access to early‐phase cancer clinical trials is heavily skewed toward urban patients treated at tertiary centers, creating significant inequity for regional/rural (R/
G. Gaughran +3 more
wiley +1 more source

Using a discrete choice experiments to explore societal preferences for valuing new drugs for rare diseases. [PDF]

Orphanet J Rare Dis
Vargas C +4 more
europepmc +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, EarlyView.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer +12 more
wiley +1 more source

Provider billing margin and cancer treatment selection: population based cohort study.

BMJ
Mitchell AP +15 more
europepmc +1 more source

The Financial Sustainability of Programs to Initiate Medications for Opioid Use Disorder in Emergency Department Settings. [PDF]

Acad Emerg Med
Hodgkin D +6 more
europepmc +1 more source

The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

Allergy, EarlyView.
ABSTRACT This update and revision of the international guideline for urticaria was developed in accordance with the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. It is an initiative of the Global Allergy and Asthma Excellence Network (GA2LEN) and its Urticaria and ...
T. Zuberbier +221 more
wiley +1 more source

Study on the medical behaviors of residents in Yicheng District of Zhumadian. [PDF]

Front Public Health
Nie Y, Du Y.
europepmc +1 more source

Early Risk Assessment and Recognition of Allergies in Children: Rationale, Methodology, and Proposed Algorithms

Allergy, EarlyView.
ABSTRACT Background Atopic diseases—including atopic dermatitis (AD), food allergy (FA), allergic rhinitis (AR), and asthma—are the most common chronic conditions in childhood and adolescence, affecting up to 30% of the global population. In Germany alone, more than 2.1 million children and adolescents are affected.
E. Hamelmann +13 more
wiley +1 more source

Comorbid Chronic Rhinosinusitis and Asthma: Shared Risk Factors and Treatment Implications—An EAACI Task Force Report

Allergy, EarlyView.
ABSTRACT Chronic rhinosinusitis (CRS) and asthma are prevalent conditions that often coexist. These diseases share common inflammatory mechanisms, such as T‐helper cell 2 (T2)‐high inflammation, driven by interleukin (IL)‐4, IL‐5, and IL‐13 cytokines.
Sanna Toppila‐Salmi +21 more
wiley +1 more source

3. good health
humans
united states

economics, hospital
motivation
reimbursement

costs and cost analysis
hospital administration
reimbursement mechanisms